Eleclazine (GS-6615) is a novel and selective voltage-gated sodium channel inhibitor with antiarrhythmic properties that reduces peak sodium current (INaP) recorded from human induced pluripotent stem cell-derived cardiomyocytes.
Molecular Weight:
415.37
Purity:
98.67%
CAS Number:
[1443211-72-0]
Formula:
C21H16F3N3O3
Target:
Sodium Channel|||Potassium Channel
T71945
T71945
* VAT and and shipping costs not included. Errors and price changes excepted